Back to search

Article

In-Silico Design of Peptides for Inhibition of HLA-A*03-KLIETYFSK Complex as a New Drug Design for Treatment of Multiples Sclerosis Disease

2021-06-22

Abstract excerpt

<title>Abstract</title> <p>Multiple sclerosis is recognized as a chronic inflammatory disease. Human leukocyte antigen (HLA) plays an important role in initiating adaptive immune responses. HLA class I is present in almost all nucleated cells and presents the cleaved endogenous peptide antigens to cytotoxic T cells. HLA-A*03 is one of the HLA class I alleles, which is reported as substantially related HLA to MS d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ea81ffdd-032f-5c7b-b053-6fd0ff9ab59c
DOI
10.21203/rs.3.rs-629231/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In-Silico Design of Peptides for Inhibition of HLA-A*03-KLIETYFSK Complex as a New Drug Design for Treatment of Multiples Sclerosis DiseaseDOI 10.21203/rs.3.rs-629231/v1
Select a neighboring publication to make it the new centre.